Amici Clinical Research LLC

1. Pfizer Inc. $6,405,396 297 payments
2. Eli Lilly and Company $5,551,762 19 payments
3. BioNTech SE $996,427 95 payments
4. Intercept Pharmaceuticals, Inc. $673,252 125 payments
5. AbbVie, Inc. $605,179 122 payments
6. Merck Sharp & Dohme Corporation $507,789 10 payments
7. Allergan Inc. $155,154 36 payments
8. Sanofi US Services Inc. $68,608 31 payments
9. Genentech, Inc. $67,730 11 payments
10. Regeneron Pharmaceuticals, Inc. $18,175 17 payments

1. A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease $4,907,023 2 payments
2. A Phase 123 Placebocontrolled Randomized Observerblind Dosefinding Study to Evaluate the Safety Tolerability Immunogenicity and Efficacy of Sarscov2 Rna Vaccine Candidates Against Covid19 in Healthy Adults $3,774,384 95 payments
3. A Phase 3 Study to Evaluate the Efficacy Immunogenicity and Safety of Respiratory Syncytial Virus RSV Prefusion F Subunit Vaccine in Adults $1,137,723 35 payments
4. Bnt162-17 $957,005 80 payments
5. A Phase 3 Master Protocol to Evaluate Additional Doses of Bnt162b2 in Healthy Individuals Previously Vaccinated With Bnt162b2 $568,776 29 payments
6. A Phase 3 Randomized Observerblind Study to Evaluate the Safety Tolerability and Immunogenicity of Multiple Production Lots and Dose Levels of the Vaccine Candidate Bnt162b2 Against Covid19 in Healthy Participants 12 Through 50Years of Age and the Safety Tolerability and Immunogenicity of Bnt162b2 Rnabased Covid19 Vaccine Candidates As A Booster Dose in Healthy Participants 18 Through 50Years of Age $476,948 12 payments
7. A Phase 2,3, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MK-4482 in Non-Hospitalized Adults with COVID-19. $425,902 4 payments
8. 1011866 $375,638 68 payments
9. A Donanemab (Ly3002813) Prevention Study in Participants With Alzheimer's Disease (Trailblazer-Alz 3) $363,511 2 payments
10. M16-100 $285,195 62 payments

1. Patient care $39,422 15 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.